Glenn Baity, EVP AND GC at ACADIA PHARMACEUTICALS INC (ACAD), sold 36,558 shares at $32.39 ($1.2M) on 2018-01-29, disclosed to the SEC on 2018-01-31.
Scheduled sale ($1.2M) by EVP AND GC under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| ACAD | SELL | 2017-09-01 | $924K | — | Filing → |
| ACAD | SELL | 2017-08-11 | $500K | — | Filing → |
| ACAD | SELL | 2017-07-21 | $1.1M | — | Filing → |